CTI BioPharma (CTIC) Reports Q4 Loss of $0.23
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Loss from operations: -28.66M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss from operations: -28.66M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q4 EPS of ($0.23), versus ($1.27) reported last year. Revenue for the quarter came in at $9.1 million, versus $11.3 million reported last year.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
